Servier Laboratories

Servier is a global independent pharmaceutical group governed by a non-profit foundation, headquartered in Suresnes, France. The company operates across five core therapeutic areas: oncology, cardiovascular and metabolic diseases, neuroscience, and immuno-inflammation. Servier has significantly expanded its oncology portfolio in recent years through strategic acquisitions, including the oncology divisions of Shire and Agios Pharmaceuticals. With a presence in over 150 countries, the group reinvests over 20% of its healthcare revenue into research and development. Its commercial portfolio includes notable treatments such as Tibsovo for AML and Lonsurf for colorectal cancer.